McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
This article was originally published in The Tan Sheet
Executive Summary
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
You may also be interested in...
Generic Drug Competition Hearing Planned For Senate Commerce Cmte.
The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May
Generic Drug Competition Hearing Planned For Senate Commerce Cmte.
The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May
Generic Drug Competition Hearing Planned For Senate Commerce Cmte.
The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May